Infant Bacterial Therapeutics AB (publ) Cash Flow-to-Debt Ratio
Infant Bacterial Therapeutics AB (publ) cash flow-to-debt ratio. Infant Bacterial Therapeutics AB (publ) (IBT-B) has a Cash Flow-to-Debt Ratio of -0.97x as of September 2025, meaning its operating cash flow of Skr-52.25 Million could theoretically repay -1% of its total liabilities (Skr53.87 Million) in one year. Check cash flow quality index of Infant Bacterial Therapeutics AB (publ) to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Infant Bacterial Therapeutics AB (publ) (2014–2024)
Cash flow-to-debt ratio of Infant Bacterial Therapeutics AB (publ) from 2014 to 2024. Historical debt coverage capacity for Infant Bacterial Therapeutics AB (publ) across 11 annual periods. Also explore IBT-B shareholders equity momentum to track the company's year-over-year net asset growth rate.
Infant Bacterial Therapeutics AB (publ) Cash Flow-to-Debt Ratio by Year (2014–2024)
Infant Bacterial Therapeutics AB (publ) cash flow-to-debt ratio by year from 2014 to 2024. Year-by-year debt coverage analysis for Infant Bacterial Therapeutics AB (publ). For the full cash flow conversion analysis, see cash flow conversion of Infant Bacterial Therapeutics AB (publ).
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.63x | Skr-113.13 Million | Skr69.30 Million | ▲ +25.5% |
| 2023 | -2.19x | Skr-101.22 Million | Skr46.18 Million | ▲ +54.2% |
| 2022 | -4.79x | Skr-85.80 Million | Skr17.91 Million | ▼ -13.9% |
| 2021 | -4.21x | Skr-55.62 Million | Skr13.22 Million | ▲ +26.8% |
| 2020 | -5.74x | Skr-58.39 Million | Skr10.16 Million | ▲ +11.8% |
| 2019 | -6.51x | Skr-51.30 Million | Skr7.88 Million | ▲ +8.6% |
| 2018 | -7.12x | Skr-47.41 Million | Skr6.65 Million | ▼ -36.4% |
| 2017 | -5.23x | Skr-34.76 Million | Skr6.65 Million | ▲ +35.8% |
| 2016 | -8.14x | Skr-39.75 Million | Skr4.88 Million | ▼ -269.8% |
| 2015 | -2.20x | Skr-17.02 Million | Skr7.73 Million | ▼ -104.6% |
| 2014 | -1.08x | Skr-3.77 Million | Skr3.51 Million | — |